HARTE-HANKS INC's ticker is HHS and the CUSIP is 416196103.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $22,000 | -31.2% | 24,767 | -14.8% | 0.00% | – |
Q3 2017 | $32,000 | +10.3% | 29,059 | 0.0% | 0.00% | – |
Q2 2017 | $29,000 | -29.3% | 29,059 | -0.4% | 0.00% | – |
Q1 2017 | $41,000 | -12.8% | 29,175 | -5.5% | 0.00% | – |
Q4 2016 | $47,000 | -81.1% | 30,875 | -79.9% | 0.00% | – |
Q3 2016 | $249,000 | +11.7% | 153,514 | +9.5% | 0.00% | – |
Q2 2016 | $223,000 | -92.2% | 140,250 | -87.5% | 0.00% | – |
Q1 2016 | $2,845,000 | -33.3% | 1,124,540 | -14.5% | 0.00% | – |
Q4 2015 | $4,264,000 | -1.4% | 1,314,954 | +7.3% | 0.00% | -100.0% |
Q3 2015 | $4,325,000 | -41.2% | 1,225,749 | -0.7% | 0.00% | 0.0% |
Q2 2015 | $7,359,000 | -23.5% | 1,233,996 | +0.1% | 0.00% | 0.0% |
Q1 2015 | $9,614,000 | +8.4% | 1,232,618 | +7.6% | 0.00% | 0.0% |
Q4 2014 | $8,867,000 | +16.5% | 1,145,338 | -4.2% | 0.00% | 0.0% |
Q3 2014 | $7,610,000 | -7.5% | 1,195,062 | +4.5% | 0.00% | 0.0% |
Q2 2014 | $8,224,000 | -14.6% | 1,143,945 | +5.0% | 0.00% | 0.0% |
Q1 2014 | $9,630,000 | -32.3% | 1,089,495 | -47.3% | 0.00% | 0.0% |
Q4 2013 | $14,227,000 | +58.8% | 2,069,056 | +104.0% | 0.00% | 0.0% |
Q3 2013 | $8,957,000 | +12.2% | 1,014,316 | +9.3% | 0.00% | 0.0% |
Q2 2013 | $7,983,000 | – | 927,898 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fondren Management LP | 1,388,000 | $1,430,000 | 1.56% |
Eidelman Virant Capital | 2,401,600 | $2,473,000 | 1.43% |
VIEX Capital Advisors, LLC | 2,205,492 | $2,272,000 | 1.26% |
BOOTHBAY FUND MANAGEMENT, LLC | 326,692 | $336,000 | 0.07% |
SHEPHERD KAPLAN KROCHUK, LLC | 48,664 | $50,000 | 0.03% |
Foundry Partners, LLC | 520,175 | $536,000 | 0.02% |
Spark Investment Management LLC | 230,500 | $237,000 | 0.02% |
TFS CAPITAL LLC | 17,419 | $18,000 | 0.01% |
ROYCE & ASSOCIATES LP | 693,472 | $714,000 | 0.01% |
Tower Research Capital LLC (TRC) | 44,392 | $45,000 | 0.01% |